AstraZeneca has unveiled plans to invest £2bn in Beijing months after Chinese authorities detained the company’s local boss ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Pharmaceutical giant Johnson&Johnson became the latest company to announce a massive investment in the U.S. to appease President Donald Trump.

In a press release on March 21, Premier Danielle Smith and Health Minister Adriana LaGrange announced that the province is ...

This $2.5 billion investment reflects AstraZeneca's belief in "the world-class life sciences ecosystem in Beijing" and its ...

Alnylam Pharmaceuticals gains FDA approval for Amvuttra in ATTR-CM, boosting revenue prospects. Click here to read an ...

AstraZeneca has announced a $2.5 billion investment in a research and development hub in Beijing, underscoring its commitment ...

Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free ...

Rio Tinto wants to increase spending in the U.S., especially in copper, the head of the company's copper business told The ...

China's commitment to foster innovation and advance high-standard opening-up has provided global pharmaceutical companies ...